2022
DOI: 10.1371/journal.pone.0263311
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic and immune-related value of STK17B in skin cutaneous melanoma

Abstract: Skin cutaneous melanoma (SKCM) is a common cancer of which mortality is increasing continuously. Our study conducted a series of analyses on the clinical significance of Serine/threonine kinase 17B (STK17B) in SKCM to provide a new biomarker for diagnosis and treatment. The RNA-sequence data were obtained from The Cancer Genome Atlas and Genotype-Tissue Expression databases. The data of 468 SKCM patients were divided into STK17B high- and low-expression groups and analyzed by Bioconductor package to identify t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 31 publications
0
5
0
Order By: Relevance
“…Furthermore, we performed survival analysis using the genes in SCARP-derived GRN and found that many genes’ abnormal expressions were associated with the poor prognoses, such as TRIM69 , MITF and STK17B ( Figure 5E and Supplementary Figure 31 ). In particular, the low expression of gene STK17B , which has been shown in the literature to play an important role in immune infiltration, was associated with skin cancer, making it a key biomarker for the diagnosis of melanoma disease [ 52 ].…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, we performed survival analysis using the genes in SCARP-derived GRN and found that many genes’ abnormal expressions were associated with the poor prognoses, such as TRIM69 , MITF and STK17B ( Figure 5E and Supplementary Figure 31 ). In particular, the low expression of gene STK17B , which has been shown in the literature to play an important role in immune infiltration, was associated with skin cancer, making it a key biomarker for the diagnosis of melanoma disease [ 52 ].…”
Section: Resultsmentioning
confidence: 99%
“…26). In particular, the low expression of gene STK17B , which has been shown in the literature to play an important role in immune infiltration, was associated with skin cancer, making it a key biomarker for the diagnosis of melanoma disease [51].…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, it is of great necessity to investigate the molecular signaling pathways and mechanisms of DRAK2-mediated CLL. Recent studies have shown that DRAK2 expression is down-regulated in skin cutaneous melanoma (SKCM) . Furthermore, the low expression of DRAK2 is linked to poor clinical prognosis and low survival rates in SKCM patients, but the mechanism needs further confirmation .…”
Section: The Dapk Family In Diseasesmentioning
confidence: 99%
“…168 Furthermore, the low expression of DRAK2 is linked to poor clinical prognosis and low survival rates in SKCM patients, but the mechanism needs further confirmation. 168 Notably, studies have demonstrated that nonalcoholic steatohepatitis (NASH) is an advanced stage of nonalcoholic fatty liver disease (NAFLD) and that DRAK2 is significantly upregulated in the livers of NAFLD/NASH patients and NAFLD/NASH diet-fed mice. 169 Mechanistically, DRAK2 interacts directly with serine/ arginine-rich (SR) splicing factor 6 (SRSF6) and prevents SRSF6 phosphorylation by inhibiting the interaction of SRSF6 with SRSF protein kinase 1 (SRPK1) (Table 4, Figure 2C).…”
Section: Drak2 In Diseasesmentioning
confidence: 99%
See 1 more Smart Citation